A number of derivatives of the mono-amine oxidase inhibitor (MAOI) compound, phenelzine, have been shown to have an anti-fertility effect, when administered both before and after implantation in mice. The action of the compounds in the pre-implantation period (days 1\ p=n-\ 6) is reversed by progesterone and by prolactin; both have to be given with 0\m=.\05\ g=m\goestradiol/ mouse during days 4 and 5 to induce implantation. When the oestrogen treatment is omitted implantation is delayed by 2\p=n-\3 days. This seems to be due to a transient antagonism of the action of luteinizing hormone (LH), which is necessary for the secretion of oestrogen which in turn is necessary for implantation. In addition, the MAOI compounds appear to inhibit the release of pituitary hormones necessary for the maintenance of pregnancy. In the pre-implantation period the important pregnancy-maintaining hormone seems to be prolactin, and after implantation LH seems to become the main luteotrophin.